Big Pharma is feeling the need to find new products with blockbuster potential as important...

|By:, SA News Editor

Big Pharma is feeling the need to find new products with blockbuster potential as important patents expire. Likely buyout targets include AMLN, UTHR, ALXN. ONXX and VRTX, Barron's says.